List view / Grid view

Immuno-oncology therapeutics

 

article

The future of cancer immunotherapy with Elicio Therapeutics

1 March 2024 | By ,

In this exclusive interview with Dr Christopher Haqq, Executive Vice President, Head of Research and Development, and Chief Medical Officer of Elicio Therapeutics, we explore the latest in Cancer Immunology Research. The study highlights the promising preclinical data demonstrating the potential of TCR-T cell therapy in combination with lymph node-targeted…

article

Chemotherapy-free treatment for patients with blood cancer

8 June 2023 | By

Dr Andy Souers highlights the unwavering commitment to finding an enhanced therapeutic approach that eliminates the need for chemotherapy in blood cancer treatment. This transformative discovery represents a significant leap forward in the way we combat this complex disease, offering new hope to countless patients worldwide.